These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35537094)

  • 1. HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
    Ussery F; Bachanas P; Alwano MG; Lebelonyane R; Block L; Wirth K; Ussery G; Sento B; Gaolathe T; Kadima E; Abrams W; Segolodi T; Hader S; Lockman S; Moore J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):9-16. PubMed ID: 35537094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
    Makhema J; Wirth KE; Pretorius Holme M; Gaolathe T; Mmalane M; Kadima E; Chakalisa U; Bennett K; Leidner J; Manyake K; Mbikiwa AM; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Lebelonyane R; Alwano MG; Powis KM; Dryden-Peterson SL; Kgathi C; Novitsky V; Moore J; Bachanas P; Abrams W; Block L; El-Halabi S; Marukutira T; Mills LA; Sexton C; Raizes E; Gaseitsiwe S; Bussmann H; Okui L; John O; Shapiro RL; Pals S; Michael H; Roland M; DeGruttola V; Lei Q; Wang R; Tchetgen Tchetgen E; Essex M; Lockman S
    N Engl J Med; 2019 Jul; 381(3):230-242. PubMed ID: 31314967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
    Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.
    Resch SC; Foote JHA; Wirth KE; Lasry A; Scott JA; Moore J; Shebl FM; Gaolathe T; Feser MK; Lebelonyane R; Hyle EP; Mmalane MO; Bachanas P; Yu L; Makhema JM; Holme MP; Essex M; Alwano MG; Lockman S; Freedberg KA
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):399-407. PubMed ID: 35420554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.
    Wester CW; Koethe JR; Shepherd BE; Stinnette SE; Rebeiro PF; Kipp AM; Hong H; Bussmann H; Gaolathe T; McGowan CC; Sterling TR; Marlink RG
    AIDS; 2011 Jul; 25(12):1471-9. PubMed ID: 21572309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).
    Marukutira T; Block L; Alwano MG; Behel S; Jarvis JN; Chakalisa U; Powis K; Novitsky V; Bapati W; Wang H; Ussery F; Lebelonyane R; Mills LA; Moore J; Bachanas P
    PLoS One; 2019; 14(8):e0221629. PubMed ID: 31465494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project.
    Alwano MG; Bachanas P; Block L; Roland M; Sento B; Behel S; Lebelonyane R; Wirth K; Ussery F; Bapati W; Motswere-Chirwa C; Abrams W; Ussery G; Miller JA; Bile E; Fonjungo P; Kgwadu A; Holme MP; Del Castillo L; Gaolathe T; Leme K; Majingo N; Lockman S; Makhema J; Bock N; Moore J
    PLoS One; 2019; 14(11):e0225076. PubMed ID: 31765394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.
    Marukutira T; Stoové M; Lockman S; Mills LA; Gaolathe T; Lebelonyane R; Jarvis JN; Kelly SL; Wilson DP; Luchters S; Crowe SM; Hellard M
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29508945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
    Tenforde MW; Mokomane M; Leeme T; Patel RKK; Lekwape N; Ramodimoosi C; Dube B; Williams EA; Mokobela KO; Tawanana E; Pilatwe T; Hurt WJ; Mitchell H; Banda DL; Stone H; Molefi M; Mokgacha K; Phillips H; Mullan PC; Steenhoff AP; Mashalla Y; Mine M; Jarvis JN
    Clin Infect Dis; 2017 Sep; 65(5):779-786. PubMed ID: 28505328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey.
    Mine M; Stafford KA; Laws RL; Marima R; Lekone P; Ramaabya D; Makhaola K; Patel HK; Mapondera P; Wray-Gordon F; Agbakwuru C; Okui L; Matroos S; Onyadile E; Ngidi J; Abimiku A; Bagapi K; Nkomo B; Bodika SM; Kim KJ; Moloney M; Mitchell A; Ehoche A; Ussery FL; Hong SY; Keipeile S; Matlhaga M; Mathumo R; Selato R; Charurat ME; Voetsch AC
    Lancet HIV; 2024 Apr; 11(4):e245-e254. PubMed ID: 38467135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa.
    Birdthistle I; Kwaro D; Shahmanesh M; Baisley K; Khagayi S; Chimbindi N; Kamire V; Mthiyane N; Gourlay A; Dreyer J; Phillips-Howard P; Glynn J; Floyd S
    PLoS Med; 2021 Oct; 18(10):e1003837. PubMed ID: 34695112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
    Bachanas P; Alwano MG; Lebelonyane R; Block L; Behel S; Raizes E; Ussery G; Wang H; Ussery F; Pretorius Holme M; Sexton C; Pals S; Lasry A; Del Castillo L; Hader S; Lockman S; Bock N; Moore J
    PLoS One; 2021; 16(4):e0250211. PubMed ID: 33882092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa.
    Fatti G; Shaikh N; Jackson D; Goga A; Nachega JB; Eley B; Grimwood A
    PLoS One; 2017; 12(7):e0181691. PubMed ID: 28750070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009.
    Diez M; Bleda MJ; Varela JR; Ordonana J; Azpiri MA; Vall M; Santos C; Viloria L; de Armas C; Urena JM; Trullen J; Pueyo I; Martinez B; Puerta T; Vera M; Sanz I; Junquera ML; Landa MC; Martinez E; Camara MM; Belda J; Bru FJ; Diaz A;
    Euro Surveill; 2014 Nov; 19(47):20971. PubMed ID: 25443036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
    N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.